Latest News about CMPS
Recent news which mentions CMPS
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
Uncovering Potential: Compass Pathways's Earnings Preview
October 30, 2024
Tickers
CMPS
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
From Benzinga
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
From Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
From Benzinga
From Benzinga
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript
August 01, 2024
Tickers
CMPS
From Motley Fool
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
From Benzinga
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
From InvestorPlace
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
July 08, 2024
From InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
From InvestorPlace
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
June 10, 2024
Tickers
CMPS
From Motley Fool
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 05, 2024
From Benzinga
What's Going On With MindMed And Psychedelic Stocks?
June 05, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
CMPS
From Motley Fool
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
From Benzinga
Tickers
CMPS
From Motley Fool
Tickers
CMPS
From InvestorPlace
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
April 19, 2024
From Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.